Skip to content
Open access

Synthesis, Structure, and Antileishmanial Activity of Novel 1,2,4‐Trioxolanes, 1,2,4,5‐Tetraoxanes and Their Respective Deoxygenated Controls

Sep 2026 · ChemMedChem · Vol 21 · 0 citations · 39 references
Medicine

TL;DR

Among 29 compounds, tetraoxanes 27, 29, 30, 32, and 33 exhibited the highest potency against both Leishmania species, but most showed limited selectivity toward the parasite, whereas 33 demonstrated strong efficacy against L. major.

Abstract

Given the reluctance of pharmaceutical companies to invest in new antileishmanial drugs, due to high costs and low perspectives of financial return, there is growing interest in repurposing existing drugs, often a more cost‐effective and quicker strategy to launch effective therapeutic solutions. Artemisinins, used as first‐line malaria treatments, have attracted attention for their potential activity against Leishmania. The mechanisms by which artemisinins treat malaria were deeply investigated and are thought to involve peroxide cleavage with formation of radicals, alkylating molecular targets within Plasmodium. However, the action of endoperoxides on Leishmania spp. remains poorly understood. To gain insight, we undertook the synthesis and structural characterization of 1,2,4‐trioxolanes, 1,2,4,5‐tetraoxanes, and respective deoxygenated controls. The compounds were evaluated in vitro against axenic and intracellular forms of Leishmania donovani and Leishmania major. Their selectivity indexes (SIs) were determined. Among 29 compounds, tetraoxanes 27, 29, 30, 32, and 33 exhibited the highest potency against both Leishmania species, but most showed limited selectivity (SI < 10) toward the parasite. Nevertheless, 33 demonstrated strong efficacy against L. major (SI of 13.7). Comparing peroxides versus their ether controls often revealed similar activities, suggesting involvement of other mechanisms beyond the iron‐dependent peroxide activation, unlike what is described for Plasmodium.

Read PDF

Similar papers

Open access Sep 2026

Design, Synthesis, and Evaluation of New 1,4‐Naphthoquinone‐1,2,3‐triazoles as Antimalarial Agents

A new series of compounds was evaluated as prospective in vitro antimalarial agents against the chloroquine‐sensitive 3D7 and chloroquine‐resistant K1 strains of Plasmodium falciparum, and the compound bearing a 4‐chloroaryl moiety was the most active against P. falciparum.

Lina Rezainia, M. Sayahi, Eisa Kaveh Vernousfaderani et al. · 0 citations
Sep 2026

Design, Synthesis, and Fungicidal Activity Evaluation of 1,2,4-Triazole Fungicides Featuring gem-Difluoromethylthio Moiety.

The gem-difluoroalkylthio (-SCF2-) moiety has achieved great success in medicinal chemistry, but its application in agrochemicals remains underexplored because of synthetic challenges. Herein, we report a series of 1,2,4-triazole derivatives bearing the gem-difluoromethylthio group and evaluate their antifungal activit...

Jun-Qing Liang, Yu-Long Miao, Xi Cheng et al. · 0 citations
Aug 2026

Structural Diversity of 1,2,4‐, 1,3,4‐, and 1,2,5‐Oxadiazoles: Synthetic Strategies, Drug–Target Interactions, and Emerging Biological Applications

Oxadiazole is a heterocyclic molecule with five members that contains both oxygen and nitrogen, and it is part of several marketed drugs used for various purposes, highlighting its significance. Due to its broad applications, chemists continuously seek to synthesize therapeutically active oxadiazole derivatives. Thes...

B. Chauhan, A. Pareek, Y. Ratan · 0 citations
Open access Sep 2026

In Vitro Antileishmanial Activity and Cytotoxicity Evaluation of 2-(Thiophen-2-ylmethyl)quinazolin-4(3H)-one Derivatives Against Leishmania tropica and Leishmania infantum

The molecular modeling findings suggest a potential interaction between E9 and trypanothione reductase, supporting the need for further evaluation of these compounds in intracellular amastigote models and subsequent in vivo studies and suggesting that the biological activity of this compound series may differ among Lei...

Atilla Karabağ, Baycan Mor · 0 citations
Open access Oct 2026

Synthesis, Antiparasitic Activity, and ADME Profile of Morpholinephenylbenzamides: A Pharmacological Study Against Chagas Disease and Visceral Leishmaniasis

Chagas disease and leishmaniasis are neglected tropical diseases with limited treatment options. This study reports a hit‐to‐lead optimization of morpholinephenylbenzamides, starting from hit 1, which showed potent activity against Trypanosoma cruzi (IC50 0.29–0.76 μM) and Leishmania infantum (IC50 10.7 μM), despite a...

D. Farago, Daniela de Melo Resende, Mariza Gabriela Faleiro de Moura Lodi Cruz et al. · 0 citations
Open access Oct 2026

Drug repurposing-inspired design of miconazole-based 1,2,3-triazoles as antichagasic agents.

Drug-repurposing strategies have been widely explored to accelerate the development of new treatments for Chagas disease, leveraging compounds with previously established safety profiles. Among these, azole antifungals have attracted attention due to their inhibitory activity against 14-α-lanosterol demethylase (CYP51)...

Mariana Araújo Marques, Augusto Vieira Pontes Silva, R. C. F. M. Reis et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.